Prevalence of HIV, HBsAg, HCV and Syphilis in Voluntary & Replacement donors at a Tertiary care Blood bank
Prevalence Of Transfusion Transmitted Infections In Blood Donors
Keywords:
Blood donors, Infectious markers, Replacement, VoluntaryAbstract
Background & Objectives: To study the prevalence of HIV, HBsAg, HCV & syphilis in blood donors.
Methods: The seroprevalence of HIV, HBsAg & syphilis among voluntary and replacement donors was analyzed for a period of 16 years (January 1996 to December 2011) and for HCV for a period of 10 years and 7 months (June 2001 to December 2011) at Department of Immunohaematology & Blood Transfusion, Civil Hospital, Ahmedabad. In this period, a total of 2, 81,665 donors were tested, out of which, 2, 00,903 (71.3%)were replacement donors and 80,762 (28.7%)were voluntary donors. HIV, HBsAg & HCV were tested by ELISA method and syphilis by RPR method. Results: Total seropositivity was 1071(0.380%) for HIV, 2900 (1.102%) for HBsAg, 599 (0.306 %) for HCV & 1522(0.540 %) for syphilis. In replacement donors, seropositivity for HIV was 891(0.443%), HBsAg was 2299(1.144%), HCV was 437(0.330%) & syphilis was 1130(0.562%). In voluntary donors, seropositivity for HIV was 180(0.222%), HBsAg was 601(0.744%), HCV was 162(0.257%) & syphilis was 392(0.485%). Conclusion: The present study indicates that higher seroprevalence rates for HIV, HBsAg, HCV & syphilis were observed in replacement donors as compared to voluntary donors
References
2. Kaur P, Basu S. Transfusion transmitted infections: Existing and emerging pathogens. Journal of Postgraduate Medicine 2005;51/2: 141-151.
3. Drug and Cosmetic Rules 1945. Schedule F : Part Xll B. In : Requirements for the functioning and operation of blood bank and/or preparation of blood components. Govt of India, Ministry of Health and Family Welfare.2005 ; 278
4. Sharma RR, Cheema R et al. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors. Natl Med J India 2004;17: 19-21.
5. Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathology & Microbiology 2001;44: 409-412.
6. Nanu A, Sharma SP, Gupta R. Infectious markers for transfusion transmissible infections in North Indian voluntary and replacement blood donors: Prevalence and trends in 1989-1996. Vox Sang 1997; 73: 70-73.
7. Mathai J, Sulochana PV et al. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerela. Indian J Pathology & Microbiology 2002; 45: 319-322.
8. Kakkar N, Kaur R, Dhanoa J. Voluntary donors – need for a second look. Indian J Pathlogy & Microbiology 2004;47:381-383.
9. Singh B, Kataria SP, Gupta R. Infectious markers in blood donors of East Delhi – prevalence and trends.Indian J Pathology & Microbiology 2004;47:477-479.
10. Chaudhary N, Ramesh V, Saraswat S, Naik S. Effectiveness of mandatory transmissible diseases screening in Indian blood donors. Indian Journal of Medical Research 1995;101:229-232.
11. Srikrishna A, Sitalakshmi S, Damodar P. How safe are our blood donors? Indian J Pathology & Microbiology 1999;42: 411-416.
12. National Blood Policy, New Delhi: National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India 2003 June; 12.
